Literature DB >> 20730728

Inappropriate sinus tachycardia - successful treatment with ivabradine.

Ozlem Ozcan Celebi1, Alper Canbay, Savas Celebi, Sinan Aydogdu, Erdem Diker.   

Abstract

Inappropriate sinus tachycardia (IST) is characterised by an exaggerated increase of heart rate in response to normal physiologic demands. Therapeutic options including medical and radiofrequency ablation interventions are still under debate. Ivabradine inhibits spontaneous pacemaker activity of the sinus node by selectively blocking If channels of pacemaker cells. Here we present a case of a patient with IST, who was successfully treated with ivabradine after various ineffective therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730728

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  2 in total

1.  Ivabradine and nightmares: a previously unreported adverse reaction.

Authors:  Knut Tore Lappegård; Elisabet Nordmo
Journal:  Eur J Clin Pharmacol       Date:  2011-06-24       Impact factor: 2.953

Review 2.  Treatment of inappropriate sinus tachycardia with ivabradine.

Authors:  Martino Annamaria; Pier Paolo Lupo; Sara Foresti; Guido De Ambroggi; Ermenegildo de Ruvo; Luigi Sciarra; Riccardo Cappato; Leonardo Calo
Journal:  J Interv Card Electrophysiol       Date:  2015-10-14       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.